AS

ASKA Pharmaceutical Holdings CO., Ltd.

Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.

4886 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区芝浦二丁目5番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ASKA Pharmaceutical Holdings Co., Ltd. is the holding company for the ASKA Pharmaceutical Group, established in April 2021. The group's core business encompasses the research, development, manufacturing, and sale of pharmaceuticals. Leveraging its long-standing expertise in hormone-related technologies, the company focuses on developing innovative and original medicines, with a particular strength in therapeutic areas such as internal medicine, obstetrics and gynecology, and urology. The group's operations also extend to the animal health and hormone testing businesses.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ASKA Pharmaceutical Holdings CO., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 08:15
Regulatory News Service
臨時報告書
Japanese 31.4 KB
2025-06-20 08:11
Regulatory News Service
確認書
Japanese 8.2 KB
2025-06-20 08:10
Regulatory News Service
内部統制報告書-第4期(2024/04/01-2025/03/31)
Japanese 28.7 KB
2025-06-20 08:08
Annual Report
有価証券報告書-第4期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-02-07 07:41
Regulatory News Service
臨時報告書
Japanese 21.4 KB
2024-11-08 07:04
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-08 07:02
Interim Report
半期報告書-第4期(2024/04/01-2025/03/31)
Japanese 183.3 KB
2024-06-28 07:12
Regulatory News Service
臨時報告書
Japanese 22.0 KB
2024-06-25 06:40
Regulatory News Service
確認書
Japanese 8.2 KB
2024-06-25 06:39
Regulatory News Service
内部統制報告書-第3期(2023/04/01-2024/03/31)
Japanese 23.6 KB
2024-06-25 06:37
Annual Report
有価証券報告書-第3期(2023/04/01-2024/03/31)
Japanese 1.3 MB
2024-02-09 07:07
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-09 07:05
Quarterly Report
四半期報告書-第3期第3四半期(2023/10/01-2023/12/31)
Japanese 155.2 KB
2023-11-10 07:23
Regulatory News Service
確認書
Japanese 8.1 KB
2023-11-10 07:18
Quarterly Report
四半期報告書-第3期第2四半期(2023/07/01-2023/09/30)
Japanese 183.9 KB

Automate Your Workflow. Get a real-time feed of all ASKA Pharmaceutical Holdings CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ASKA Pharmaceutical Holdings CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
VENTURE LIFE GROUP PLC Logo
Develops, manufactures, and distributes consumer self-care products and medical devices globally.
United Kingdom VLG
Vetoquinol SA Logo
Develops and markets veterinary drugs and products for companion animals and livestock worldwide.
France VETO
Vifor Pharma AG Logo
A global leader in specialty pharmaceuticals for iron deficiency and nephrology.
Switzerland VIFN
ViGenCell Inc. Logo
Developing T-cell immune therapies to treat cancer and other incurable diseases.
South Korea 308080
Virbac Logo
Develops animal health pharma, vaccines & diagnostics for vets, farmers & pet owners globally.
France FR000
ViroGates A/S Logo
Develops suPAR diagnostic tests for inflammation risk assessment in acute care and longevity.
Denmark VIRO
Vistin Pharma Logo
A leading global producer of Metformin Hydrochloride for the global healthcare market.
Norway VISTN
Vita 34 AG Logo
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
Germany V3V
Vivoryon Therapeutics N.V. Logo
Developing first-in-class small molecule therapies for age-related and kidney diseases.
Germany VVY
Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.
South Korea 082800

Talk to a Data Expert

Have a question? We'll get back to you promptly.